Jennison Associates
DPLO

Jennison Associates’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Jennison Associates’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-15,988
Closed -$409K – 723
2018
Q2 		$409K Sell
15,988
-1,426
-8% -$33.2K ﹤0.01% 635
2018
Q1 		$351K Buy
17,414
+2,055
+13% +$47.9K ﹤0.01% 624
2017
Q4 		$308K Buy
+15,359
New +$302K ﹤0.01% 642

Other funds holding DPLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Jennison Associates's DPLO Position: Q3 2018 in Review

Jennison Associates sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 15,988 shares — an estimated $409K sold.

Jennison Associates first reported a position in DPLO in Q4 2017 and held it in 3 quarters. The position peaked at $409K in Q2 2018. 177 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

  • Jennison Associates reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
  • Jennison Associates sold 15,988 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $409K.
  • Jennison Associates first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 3 quarters.
  • Jennison Associates's DIPLOMAT PHARMACY, INC. position peaked at $409K in Q2 2018.
  • 177 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.